Sex-specific differences in side effects of psychotropic drugs: genes or gender?

Weight gain during treatment with valproate

(2010) Hanne Dinesen et al.   ACTA NEUROLOGICA SCANDINAVICA

Tardive dyskinesia and new antipsychotics

(2009) Christoph U Correll et al.   CURRENT OPINION IN PSYCHIATRY

Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine

(2009) Arzu Gunes et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication

(2009) Jochem G. Gregoor et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia

(2009) Hans Mulder et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

(2009) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight effects associated with antipsychotics: A comprehensive database analysis

(2009) Bruce Parsons et al.   SCHIZOPHRENIA RESEARCH

Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine

(2008) Martha J. Morrell et al.   ANNALS OF NEUROLOGY

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

(2008) Olga O. Yevtushenko et al.   BRITISH JOURNAL OF PSYCHIATRY

Polycystic ovary syndrome in women using valproate: A review

(2008) Leonilda Bilo et al.   GYNECOLOGICAL ENDOCRINOLOGY

Prevalence of Metabolic Syndrome among Inpatients with Schizophrenia

(2008) Omer Boke et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE

The Association Between Carbamazepine and Valproate and Adverse Cutaneous Drug Reactions in Patients With Bipolar Disorder

(2008) Susan Shur-Fen Gau et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes

(2008) Vibhuti Srivastava et al.   PHARMACOGENOMICS

Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics

(2008) BK Thelma et al.   PHARMACOGENOMICS

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants

(2008) Vicki L. Ellingrod et al.   SCHIZOPHRENIA RESEARCH